Uploaded by Emily Shoemaker

Assesment Hemo for Class Use

advertisement
Perfusion, Cellular Regulation
Assessment of the
Hematologic System
C.Bailey, DNP, RN, CNE 8/09; Rev 7/11, 3/17, 3/20
Anatomy & Physiology Review


Bone marrow
Blood components





Red blood cells (erythrocytes)
White blood cells
Platelets
Plasma
Accessory organs


Spleen
Liver
Weni Carpenter, MSN, RN 2018
Erythrocytes (RBCs)


Transport gases
Erythropoiesis


Erythropoietin
Essential nutrients
• Iron
• cobalamin (vit.
B12)
• folic acid

Reticulocyte

Immature RBC
Erythrocytes (RBCs)

Hemoglobin
 Iron + Protein
 Oxygen binder

Hemolysis


Occurs in bone marrow, liver, spleen
Increases bilirubin in blood
Lab Values




Red Blood Cell Count (RBC)
4.7 – 6.1 x 106/µL (Male)
4.2 – 5.4 x 106/µL (Female)
Reticulocyte Count





.5% - 2%
Hematocrit (Hct) 42 - 52% (Male)
37-47% (Female)
Hemoglobin (Hgb) 14 - 18 gm/dL (Male)
12 - 16 gm/dL (Female)
Lab Values

Mean corpuscular volume (MCV)


Mean Corpuscular Hemoglobin (MCH)


83-100 fL
27-34 g/dL
Mean Corpuscular Hemoglobin
Concentration (MCHC)

32%-37%
Leukocytes (WBC’s)

WBC’s (5,000 – 10,000 µL)

What’s a “Differential”?

Developmental considerations

Effects of Steroids
Assessment

Assessing without labs

Where would you look?

What might you see in high RBC or low?

Signs and symptoms
Granulocytes

Neutrophils: Injury/infection/inflammation


Segmented “Segs”: (50% - 70%)
Band: (0% - 8%)

Eosinophils: (0% - 4%) Allergic reaction

Basophils: (0% - 2%) Limited allergic and
inflammation
Agranulocyte

Monocytes: (4% - 8%)
 Potent phagocytic cells
 Arrive 2nd after neutrophils
Agranulocyte


Lymphocytes: (20% - 40%)
B-Cells

Form plasma cells that produce antibodies
(immunoglobulins) that mediate humoral immunity
T-Cells

Mediate cellular immunity involved in cellular immune
response
Teamwork & Collaboration
Reflect on the core importance of lab results
in directing a patient’€
s plan of care. On a
€
systems level, what can interfere with
accuracy of reporting?
What occupational risks do our lab
colleagues accept in their work?
Example of a “Shift”
Absolute Neutrophil Count
ANC measured indirectly by multiplying the white blood cell
count times the percent of neutrophils in the differential of the
white count.
Normal range for ANC is 1.5 to 8.0
(1500 to 8000/mm3.)
Sample Calculation
WBC count: 6,000 cells/mm3
Segs: 30% of the WBCs
Bands: 3% of the WBCs
Neutrophils (segs + bands): 33% of the WBCs
ANC: 33% X 6,000 = 2,000/mm3
ANC of 2,000/mm3, by convention = 2.0
Normal range: 1.5 to 8.0 (1,500 to 8,000/mm3)
Interpretation: Normal
Assessment

Assessing without labs

Where would you look?

What might you see in high RBC or low?

Signs and symptoms
Think, Pair, Share

If you see an increase in neutrophils with a
rise in bands………

If you see increased lymphocytes with a
decline in total WBC…….

If you see normal WBC in person taking
long-term steroids………
Lymph System

Fluid

Nodes

Spleen
How can we use to assess?
Thrombocytes: Platelets

(150- 400 X 103/µL)




Thrombocytopenia
Aid in blood clotting
Maintain capillary integrity
Damage occurs  platelets activated
 Also act to shrink & retract clots
Normal Clotting Mechanisms

Three components

Vasoconstriction
 Platelet plug the hole
 Activate clotting factors (I – XIII)  thrombin converts
fibrinogen to fibrin
 Lysis of clot (Reset)
Labs Associated with Clotting

Bleeding and Coagulation




Prothrombin Time (PT)
• 11 - 12 sec
International Normalized Ratio (INR)
• Normal: 1
• Warfarin therapy (Coumadin) 2 – 3
Partial Thromboplastin Time (PTT)
• Normal: 21 – 35 sec
Anti-factor Xa (Anti-Xa)
• 0.5 – 1.0 IU/mL
• 0.3 - 0.7 IU/mL (LMWH)
Medications & Clotting!!

Binds to anti-thrombin





Heparin
LMWH
• enoxaparin
Lab Assessment
Antidote
Inhibit Vitamin K synthesis

Coumadin
 Lab Assessment
 Antidote
Anticlotting Forces
Medications & Clotting!

Factor XA Anticoagulants (Direct Thrombin Inhibitors)




apixaban (Eliquis)
rivaroxaban (Xarelto)
dabigatran (Pradaxa)
Antidote for dabigatran
• andexanet alfa (IV bolus)
Medications and Clotting!

Fibrinolytic Medications “Clot busters”






Tissue Plasminogen Activator
Streptokinase
Tenecteplase
Alteplase
Reteplase
Anistreplase
Hemostasis/Blood Clotting

Create a list of priority nursing interventions
for a patient with a traumatized blood vessel.
Hemo Assessment
Without looking in your book, develop a list of
questions the nurse would ask the client
regarding:






Physiological questions
Family history
Genetic history
Work history
Environmental hazards
Nutritional status
Physical Assessment

Without looking at your book, computer, or phone
(this means you!) list findings the nurse might expect
in a person with an oxygen delivery/tissue perfusion
problem?

Skin
Head and neck
Respiratory
Cardiovascular
Renal and urinary
Musculoskeletal
Abdominal
Central nervous system
Psychosocial








HCO3
Bone Marrow Aspiration
Bone Marrow Aspiration
and Biopsy




How would you prepare the patient for this
procedure?
What nursing care is necessary during the
procedure?
How will the nurse care for the patient after
the procedure, including preparation for
discharge?
What follow-up care is necessary?
Growth and Develop

Differences in young

Difference in elderly

Medical comorbitites
Question 1
A nurse interviews an older female patient who reports
progressive fatigue, shortness of breath, and
headaches. What question should the nurse ask first to
collect more data surrounding the possible cause of the
patient’s symptoms?
A.
B.
C.
D.
“Do you have a history of cardiovascular disease?”
“Can you tell me about your diet?”
“Have you been feeling depressed lately?”
“What medications do you routinely take?”
Question 2
A patient is reporting increased fatigue, malaise,
bleeding gums, and frequent “chills.” What is the most
appropriate initial nursing intervention?
Notify the physician of the patient’s symptoms.
Review the laboratory analysis for signs and
symptoms of bone marrow suppression.
C. Review the laboratory analysis for signs and
symptoms of infection.
D. Obtain vital signs and blood cultures and administer
antipyretic medications.
A.
B.
Question 3
A patient is transitioning from IV heparin therapy to oral
warfarin. Therapeutic anticoagulation of the patient is
best assessed by:
A.
B.
C.
D.
Partial thromboplastin time of 24.3 seconds
Prothrombin time of 18 seconds
International normalized ratio of 2.5
Bleeding time of 5 minutes
The patient’s complete blood count shows a
hemoglobin of 20 g/dL and a hematocrit of 54%.
Which question should the nurse ask to determine
possible causes of this finding?
A. “Has there been any recent weight loss?”
B. “Do you have any history of lung disease?”
C. “What is your intake of fruits and vegetables?”
D. “Have you noticed any dark or bloody stools?”
A nurse is caring for four patients. After reviewing
today’s laboratory results, which patient should the
nurse see first?
a. Patient with an international normalized ratio of 1.2
b. Patient with a platelet count of 128,000/mm3
c. Patient with a prothrombin time (PT) of 28 seconds
d. Patient with a red blood cell count of 5.1 mil/mcL
Download